p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary.
about
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges.Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infectionPatterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy.Human papillomavirus in head and neck squamous cell carcinoma of unknown primary is a common event and a strong predictor of survival.Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck.The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review.Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters : A single-center analysis.Squamous cell carcinoma of unknown primary tumor metastatic to neck nodes: role of elective irradiation.Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.Bronchogenic cancer: It still exists.Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer.A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer.Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck
P2860
Q33634679-9CA1ABB1-1372-4D7F-80C9-64426521D6AEQ33655046-2CDE548E-9CAF-4AF5-B4B1-237101C5664CQ33785056-593380DE-0005-4DEA-9C55-D83F618D6766Q33900702-C1B0B934-3AAE-4B38-A2A2-3B012AC64149Q34450121-5A2A886E-3EFE-4821-9003-E81C9CDA06CCQ36326276-916802A9-6E8A-4647-A206-5B8BD5444C23Q38584576-02B22B43-3812-4709-A168-2C5D7074DCA0Q38763503-DF903EF9-7AFF-4B5E-B04C-F010A245A4EEQ38882088-8329F180-AFC9-4C67-85CB-5697F906BE61Q40839526-B915B8E1-4DEB-4FA0-91E9-FAAFDFBD9ABBQ41358366-3F6B0DF6-0DF2-45EC-8203-561A84FA2933Q46120977-1FBC5402-B1A5-4703-8E2B-DB323E45EF02Q48098230-21531803-5409-49D4-9655-3783F1AC6D11Q58602055-47360CAE-24B6-43ED-A246-486992B290CB
P2860
p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
p16 status, pathologic and cli ...... carcinomas of unknown primary.
@en
p16 status, pathologic and cli ...... carcinomas of unknown primary.
@nl
type
label
p16 status, pathologic and cli ...... carcinomas of unknown primary.
@en
p16 status, pathologic and cli ...... carcinomas of unknown primary.
@nl
prefLabel
p16 status, pathologic and cli ...... carcinomas of unknown primary.
@en
p16 status, pathologic and cli ...... carcinomas of unknown primary.
@nl
P2093
P2860
P356
P1433
P1476
p16 status, pathologic and cli ...... carcinomas of unknown primary.
@en
P2093
Barbara Burtness
Cara Dubyk
Donghua Yang
Douglas Flieder
John A Ridge
Karen Ruth
Lanea M Keller
Miriam N Lango
Ranee Mehra
Thomas Holdbrook
P2860
P304
P356
10.1002/HED.23514
P577
2014-01-13T00:00:00Z